Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07516483 · ClinicalTrials.gov registry record · NA
Thermal Preconditioning in Mastectomy Patients With Immediate Breast Reduction
A NA study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07516483 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 40 participants.
The verdict
NCT07516483, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand patient experiences and the feasibility of using a breast heat preconditioning device (Plexaa BLOOM43), designed to improve postoperative outcomes when used prior to mastectomy and breast reconstruction.
Interventions
- OTHER No Intervention
- OTHER 1 Cycle Thermal Preconditioning
- OTHER 3 Cycles Thermal Preconditioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07516483
The ClinicalTrials.gov registry entry for NCT07516483 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which No Intervention is the first listed.
NCT07516483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07516483 about?
NCT07516483 is a clinical study titled "Thermal Preconditioning in Mastectomy Patients With Immediate Breast Reduction". The purpose of this research study is to understand patient experiences and the feasibility of using a breast heat preconditioning device (Plexaa BLOOM43), designed to improve postoperative outcomes when used prior to mastectomy and breast reconstruction.
What is the current status of trial NCT07516483?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-07. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07516483?
The interventions under investigation include: No Intervention (OTHER), 1 Cycle Thermal Preconditioning (OTHER), 3 Cycles Thermal Preconditioning (OTHER).
Who is sponsoring clinical trial NCT07516483?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.